Combined Metabolomic Analysis of Plasma and Tissue Reveals a Prognostic Risk Score System and Metabolic Dysregulation in Esophageal Squamous Cell Carcinoma

Background: Esophageal squamous cell carcinoma (ESCC) is a gastrointestinal malignancy with a poor prognosis. Although studies have shown metabolic reprogramming to be linked to ESCC development, no prognostic metabolic biomarkers or potential therapeutic metabolic targets have been identified. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhongjian, Dai, Yalan, Huang, Xiancong, Chen, Keke, Gao, Yun, Li, Na, Wang, Ding, Chen, Aiping, Yang, Qingxia, Hong, Yanjun, Zeng, Su, Mao, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479226/
https://www.ncbi.nlm.nih.gov/pubmed/32984013
http://dx.doi.org/10.3389/fonc.2020.01545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479226/
https://www.ncbi.nlm.nih.gov/pubmed/32984013
http://dx.doi.org/10.3389/fonc.2020.01545

Ejemplares similares